ClinicalTrials.Veeva

Menu

Test-Retest Variability of Quick Contrast Sensitivity Function Testing

Nova Southeastern University (NSU) logo

Nova Southeastern University (NSU)

Status

Completed

Conditions

Healthy

Treatments

Other: quick Contrast Sensitivity Function test

Study type

Observational

Funder types

Other

Identifiers

NCT02177669
Adaptive Sensory Technology (Other Grant/Funding Number)
05291468Exp
R21EY023720 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The contrast sensitivity function (CSF) provides a comprehensive characterization of spatial vision and predicts functional vision better than visual acuity, but long testing times prevent its psychophysical assessment in clinical applications. Dr. Luis Lesmes et al. (2010) developed the qCSF method to obtain precise CSF measurements in only 30-50 trials using a computerized software program that presents letters on a large monitor that are identified by a patient similar to typical visual acuity testing with an eye chart. The quick CSF method is a Bayesian adaptive method that estimates the full shape of the CSF, and the test duration is only about 3-6 minutes. Some preliminary testing has been performed at other sites with this test in patients with vision loss due to amblyopia and glaucoma, but data from individuals without eye disease who have normal visual acuity has not been systematically collected with the latest version of this test procedure across a wide range of ages. In addition, we aim to gain a better understanding of the typical test-retest variability that is obtained between-sessions that are about a week apart from individuals with good ocular health and visual acuity.

Enrollment

100 patients

Sex

All

Ages

20 to 89 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Ages 20-89
  • Normal distance visual acuity in each of both eyes (20/20)
  • Absence of ocular disease
  • Able and willing to complete contrast sensitivity testing
  • Provide informed consent

Exclusion criteria

  • Any ocular disease
  • Refractive errors >6D
  • Inability to understand study or communicate responses (cognitive impairment)
  • Unable to understand, read and speak English fluently

Trial design

100 participants in 1 patient group

Normals without ocular disease
Treatment:
Other: quick Contrast Sensitivity Function test

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems